1. Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG;Behr;J. Nucl. Med.,1997
2. Phase II study of interferon-enhanced 131I-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancer;Meredith;Clin. Cancer Res.,1999
3. Assessment of combined radioimmunotherapy and chemotherapy for treatment of medullary thyroid cancer;Stein;Clin. Cancer Res.,1999
4. Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil);Tschmelitsch;Cancer Res.,1997
5. Phase I/II trial of combined 131I anti-CEA monoclonal antibody and hyperthermia in patients with advanced colorectal adenocarcinoma;Mittal;Cancer,1996